Chemical Biology & Drug Design

Scope & Guideline

Fostering breakthroughs in molecular medicine and drug design.

Introduction

Delve into the academic richness of Chemical Biology & Drug Design with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageEnglish
ISSN1747-0277
PublisherWILEY
Support Open AccessNo
CountryUnited Kingdom
TypeJournal
Convergefrom 2006 to 2024
AbbreviationCHEM BIOL DRUG DES / Chem. Biol. Drug Des.
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address111 RIVER ST, HOBOKEN 07030-5774, NJ

Aims and Scopes

The journal "Chemical Biology & Drug Design" focuses on the integration of chemical biology and medicinal chemistry to develop new therapeutic agents and understand their mechanisms of action. It aims to bridge the gap between chemistry and biology, emphasizing innovative drug design, synthesis, and evaluation methodologies.
  1. Medicinal Chemistry:
    The journal emphasizes the design and synthesis of novel chemical compounds with potential therapeutic applications, particularly in cancer, infectious diseases, and chronic conditions.
  2. Chemical Biology:
    Research that explores the interactions between biological systems and chemical entities, including the mechanisms behind drug action and biological pathways.
  3. Drug Development and Design:
    The journal features works related to the development of new drugs, including formulation strategies, delivery systems, and efficacy evaluations.
  4. Network Pharmacology:
    A focus on understanding the multi-target interactions of drugs within biological networks, which is essential for elucidating complex disease mechanisms.
  5. In Silico Studies:
    Emphasizes computational approaches in drug discovery, including molecular docking, QSAR modeling, and machine learning applications to predict biological activity.
  6. Natural Products Chemistry:
    Explores the therapeutic potential of natural compounds and their derivatives, focusing on their isolation, structural elucidation, and biological activities.
Recent publications in "Chemical Biology & Drug Design" indicate a shift towards innovative and interdisciplinary approaches in drug discovery and development. The following themes have emerged as significant focuses of research.
  1. Targeted Cancer Therapies:
    An increasing number of studies are focusing on targeted therapies that leverage specific molecular pathways in cancer treatment, reflecting the growing understanding of tumor biology.
  2. Combination Therapies:
    Research is trending towards exploring the efficacy of combination therapies that utilize multiple agents to enhance therapeutic outcomes and overcome resistance mechanisms.
  3. Biologics and Biopharmaceuticals:
    The emergence of biologics as therapeutic agents, including monoclonal antibodies and protein-based drugs, is gaining traction, emphasizing the need for advanced drug design techniques.
  4. Machine Learning and AI in Drug Discovery:
    The integration of machine learning and artificial intelligence into drug discovery processes is becoming increasingly prominent, aiding in predictive modeling and optimization of drug candidates.
  5. Natural Product Derivatives:
    There is a growing interest in the modification of natural products to enhance their pharmacological properties, with a focus on their potential as leads for new drug development.
  6. Nanotechnology in Drug Delivery:
    Research is increasingly focusing on the application of nanotechnology for drug delivery systems, enhancing the bioavailability and targeting of therapeutic agents.

Declining or Waning

While the journal maintains a robust focus on various emerging themes, certain areas have seen a decline in prominence over recent years. This may reflect shifts in research priorities or advancements in specific methodologies.
  1. Traditional Antimicrobial Agents:
    Research focusing on conventional antibiotics and their mechanisms has become less prevalent as the field moves towards exploring novel and multi-targeted therapeutic strategies.
  2. Single-Target Drug Design:
    There is a noticeable decrease in studies centered around single-target drugs, as the complexity of diseases has led to a shift towards multi-target approaches and combination therapies.
  3. In vitro Only Studies:
    Research that solely relies on in vitro models without in vivo validation has waned, as the scientific community increasingly emphasizes the importance of comprehensive in vivo studies to support findings.
  4. Synthetic Methods with Limited Applicability:
    The use of traditional synthetic methods without innovative adaptations or applications in drug design has seen a decline, as researchers seek more versatile and efficient synthetic strategies.

Similar Journals

MONATSHEFTE FUR CHEMIE

Connecting Researchers with Chemistry's Timeless Discoveries
Publisher: SPRINGER WIENISSN: 0026-9247Frequency: 12 issues/year

MONATSHEFTE FUR CHEMIE, an esteemed journal published by Springer Wien, has been a significant contributor to the field of chemistry since its inception in the late 19th century. With a rich history spanning from 1880 to the present, this journal provides a platform for innovative research and comprehensive reviews in various areas of general chemistry. Although it currently holds a Q3 ranking in the miscellaneous category of chemistry, its commitment to maintaining high academic standards is reflected in its continued relevance and citation impact, as evidenced by its Scopus ranking. Researchers, professionals, and students engaged in chemical sciences will find this journal a valuable resource for advancing their knowledge and contributing to ongoing discussions in the field. For those looking to stay updated on the latest developments in chemistry while engaging with a storied publication, MONATSHEFTE FUR CHEMIE is a pivotal source of insightful content.

RUSSIAN JOURNAL OF BIOORGANIC CHEMISTRY

Connecting Organic Chemistry with Biological Breakthroughs
Publisher: MAIK NAUKA/INTERPERIODICA/SPRINGERISSN: 1068-1620Frequency: 7 issues/year

Russian Journal of Bioorganic Chemistry (ISSN: 1068-1620, E-ISSN: 1608-330X), published by MAIK Nauka/Interperiodica/Springer, serves as a vital resource for researchers and professionals in the fields of bioorganic chemistry, biochemistry, and organic chemistry. With a focus on the integration of organic chemistry principles with biological processes, this journal aims to disseminate significant findings and advancements from both theoretical and practical perspectives. Although currently not open access, the journal retains a dedication to high-quality, peer-reviewed content, contributing to its reputation within the academic community. The 2023 Scopus rankings position it within the Q4 category for both biochemistry and organic chemistry, indicating its critical niche within these disciplines amid a competitive landscape. Since its inception in 1996, the journal has continued to evolve, providing enriching insights and fostering collaborations among scholars and practitioners alike, with publication converging up to the year 2024. By exploring complex biomolecular interactions and the synthesis of biologically relevant compounds, the Russian Journal of Bioorganic Chemistry remains a significant platform for advancing knowledge and innovation in the life sciences.

RSC Medicinal Chemistry

Transforming Discoveries into Healing Solutions
Publisher: ROYAL SOC CHEMISTRYISSN: Frequency: 12 issues/year

RSC Medicinal Chemistry is a pivotal journal in the realm of medicinal chemistry, published by the esteemed Royal Society of Chemistry. With a focus on innovative research that intersects various disciplines such as biochemistry, drug discovery, pharmaceutical science, and organic chemistry, this journal serves as a vital resource for researchers, professionals, and students alike. Its impressive impact factor and notable rankings—positioning it within the Q1 and Q2 quartiles across critical categories—underscore its significance in advancing knowledge and fostering collaboration within the scientific community. RSC Medicinal Chemistry is dedicated to open access, ensuring that cutting-edge findings on drug design and therapeutic applications are freely available to enhance global research efforts. With a commitment to publication excellence from 2020 to 2024, it is a prominent platform where groundbreaking ideas meet practical implications, making it indispensable for anyone committed to the forefront of medicinal advances.

BIOORGANIC & MEDICINAL CHEMISTRY

Pioneering Research in Bioorganic Science
Publisher: PERGAMON-ELSEVIER SCIENCE LTDISSN: 0968-0896Frequency: 24 issues/year

BIOORGANIC & MEDICINAL CHEMISTRY, published by Pergamon-Elsevier Science Ltd, is a prominent journal in the fields of biochemical research and drug discovery, with an ISSN of 0968-0896 and an E-ISSN of 1464-3391. Established in 1993, it has garnered respect and recognition, evidenced by its categorization in various quartile ranks across 2023, including Q2 in Clinical Biochemistry and Pharmaceutical Science. It holds significant Scopus rankings, placing it in the 75th percentile in Pharmaceutical Science and 74th percentile in Organic Chemistry, highlighting its influential contributions to ongoing research and developments. This journal provides a platform for disseminating advancements in bioorganic and medicinal chemistry, focusing on innovative methodologies, therapeutic advancements, and molecular pharmacology. Although it does not follow an open-access model, it remains a key resource for researchers, professionals, and students aiming to stay at the forefront of scientific discovery in the UK and beyond. The journal’s commitment to enhancing knowledge within the biomedical community makes it an essential read for those passionate about this dynamic field.

Medicinal Chemistry

Exploring the intricate world of medicinal chemistry.
Publisher: BENTHAM SCIENCE PUBL LTDISSN: 1573-4064Frequency: 8 issues/year

Medicinal Chemistry is a prestigious journal published by Bentham Science Publishers Ltd, dedicated to advancing the field of drug discovery and development. Established in 2005 with a converged publication timeframe extending to 2024, this journal serves as a vital resource for researchers and professionals interested in the intricate processes of medicinal chemistry, pharmacology, and toxicology. With an ISSN of 1573-4064 and an E-ISSN of 1875-6638, it has established a notable presence in the academic community, currently positioned in Q3 of Drug Discovery category according to the 2023 quartiles. The journal's ranking in Scopus places it at 90 out of 157 in its field, showcasing its impact and relevance, with a percentile standing of 42. Although the journal is not open access, it continues to provide insightful articles and research findings that contribute significantly to the understanding and innovation in medicinal chemistry. Based in the United Arab Emirates, Medicinal Chemistry is committed to disseminating high-quality research that shapes the future of drug formulation and therapeutic advancement.

Records of Natural Products

Transforming Natural Insights into Pharmaceutical Advances
Publisher: ACG PUBLICATIONSISSN: 1307-6167Frequency: 6 issues/year

Records of Natural Products is a distinguished journal focused on the dynamic fields of Drug Discovery, Organic Chemistry, Pharmacology, and Plant Science. Published by ACG PUBLICATIONS in Turkey, this journal serves as a vital platform for disseminating innovative research findings and advancements in natural product studies. With its convergence spanning from 2009 to 2024, Records of Natural Products holds a commendable position in the academic realm, featuring a 2023 Q3 ranking in Drug Discovery and Organic Chemistry, alongside a notable Q2 ranking in Plant Science. Despite its current lack of open access, the journal is committed to providing quality content that enriches the understanding of natural products and their potential applications. Researchers and professionals alike can benefit from the journal's insights, which not only contribute to scientific knowledge but also facilitate advancements in pharmaceuticals and sustainable practices. By exploring the rich tapestry of natural product research, this journal underscores its importance as a leading resource for professionals dedicated to enhancing the efficacy and application of natural compounds.

CURRENT TOPICS IN MEDICINAL CHEMISTRY

Pioneering Research for Tomorrow's Medicines
Publisher: BENTHAM SCIENCE PUBL LTDISSN: 1568-0266Frequency: 32 issues/year

CURRENT TOPICS IN MEDICINAL CHEMISTRY is a prestigious journal published by Bentham Science Publishers Ltd, dedicated to advancing the field of medicinal chemistry through the dissemination of high-quality research from 2001 to 2024. With an ISSN of 1568-0266 and an E-ISSN of 1873-4294, this journal is recognized for its significant contributions, as evidenced by its Scopus ranking in the 63rd percentile in the category of Drug Discovery, specifically at position #58 out of 157. Currently placed in Quartile 3 within Drug Discovery and Quartile 2 in miscellaneous medicine as of 2023, it serves as an essential resource for researchers, professionals, and students interested in the latest developments, methodologies, and applications in medicinal chemistry. The journal aims to foster collaboration and innovation by featuring original research articles, reviews, and brief communications that address current and emerging challenges in the discipline. Although it is not an open access platform, the journal's rich content is indispensable for those striving to enhance therapeutic strategies and drug development processes.

ChemMedChem

Innovating drug discovery through interdisciplinary collaboration.
Publisher: WILEY-V C H VERLAG GMBHISSN: 1860-7179Frequency: 24 issues/year

ChemMedChem is a leading international journal published by WILEY-V C H VERLAG GMBH in the United Kingdom, specializing in the interdisciplinary fields of medicinal chemistry and drug discovery. With a commendable impact factor that places it in the Q1 quartile for Organic Chemistry and among the Q2 ranks in several other key categories including Biochemistry, Molecular Medicine, and Pharmacology, ChemMedChem serves as a vital platform for the dissemination of innovative research and transformative insights in the development of pharmaceutical agents. Since its inception in 2006, this journal has been at the forefront of advancing knowledge that bridges the gap between fundamental research and practical applications in medicine, making it an essential resource for researchers, professionals, and students alike. Although it currently does not offer Open Access options, the journal ensures high-quality peer-reviewed content that engages its audience and fosters collaborative scientific discourse.

TURKISH JOURNAL OF CHEMISTRY

Inspiring Breakthroughs in Chemical Science
Publisher: Tubitak Scientific & Technological Research Council TurkeyISSN: 1300-0527Frequency: 6 issues/year

TURKISH JOURNAL OF CHEMISTRY, published by the Tubitak Scientific & Technological Research Council Turkey, serves as a significant platform for the dissemination of research in the diverse field of chemistry. Since its inception in 1996, this peer-reviewed journal has made substantial contributions to the body of knowledge within the field, currently holding a respectable Q3 ranking in the category of Chemistry (miscellaneous) as of 2023. Researchers and professionals alike rely on this journal for its wide-ranging discussions, innovative methodologies, and noteworthy findings pertinent to both fundamental and applied chemistry. With an ISSN of 1300-0527 and a commitment to promoting scientific progress, the journal is accessible to a global audience and encourages the open sharing of insights that drive advancements in chemistry. The extended timeframe of convergence until 2024 highlights the journal's dedication to fostering ongoing research and collaboration within the scientific community. As a valuable resource for researchers, professionals, and students, the Turkish Journal of Chemistry aims to inspire new discoveries and facilitate knowledge transfer in a dynamic and evolving discipline.

JOURNAL OF ASIAN NATURAL PRODUCTS RESEARCH

Cultivating Insights in Complementary Medicine
Publisher: TAYLOR & FRANCIS LTDISSN: 1028-6020Frequency: 12 issues/year

JOURNAL OF ASIAN NATURAL PRODUCTS RESEARCH is a prestigious publication in the field of natural products, focusing on valuable research spanning analytical chemistry, pharmacology, and complementary medicine. Published by Taylor & Francis Ltd in the United Kingdom, this journal has established itself as a key resource for academics and professionals seeking to explore advancements in drug discovery and organic chemistry. With a converged publication timeline from 1998 to 2024, the journal boasts several commendable category quartiles as of 2023, reflecting its robust standing in the research community: Q2 in Complementary and Alternative Medicine, Q3 in multiple domains including Analytical Chemistry and Organic Chemistry, and Q4 in Molecular Medicine. Although it currently does not offer open access, the journal remains a valuable compendium for empirical research and innovative studies in areas such as pharmacology and medicinal chemistry. Researchers, professionals, and students alike will find the JOURNAL OF ASIAN NATURAL PRODUCTS RESEARCH to be an essential platform for sharing groundbreaking findings and fostering collaborations that lead to significant advancements in science and health.